Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

September 30, 2012

Conditions
Typical Atrial Flutter
Interventions
DEVICE

Treatment Arm

The investigational parts of the system consists of Contact Therapy Cool Path ablation catheter, 1500 T9 V1.43 RF Generator, Model 1611 connection cable, EnSite Velocity Contact™ Kit, and EnSite Velocity Contact software controlled via entitlement .

Trial Locations (20)

10016

New York University Langone Medical Center - Tisch Hospital, New York

14642

University of Rochester, Rochester

18901

Doylestown Hospital, Doylestown

23229

Virginia Cardiovascular Specialists, Richmond

27599

University of North Carolina at Chapel Hill, Chapel Hill

28204

Presbyterian Hospital, Charlotte

30322

Emory University Hospital, Atlanta

32204

St. Vincent's Hospital, Jacksonville

35211

Cardiology, P.C., Birmingham

43215

Ohio Health Research Institute - GMC, Columbus

60637

University of Chicago, Chicago

70121

Ochsner Medical Center, New Orleans

75231

Texas Health Research & Education Institute, Dallas

76508

Scott & White Memorial Hospital, Temple

77030

Memorial Hermann Hospital, Houston

St. Luke's Episcopal Hospital, Houston

80012

Aurora Denver Cardiology, Denver

97225

Providence St. Vincent Medical Center, Portland

06102

Hartford Hospital, Hartford

H1T 1C8

Institut de Cardiologie de Montreal (Montreal Heart Inst.), Montreal

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT01401361 - Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System | Biotech Hunter | Biotech Hunter